Northwest Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Northwest Capital Management's AMGN Position: Q4 2025 in Review
Northwest Capital Management reduced its Amgen (AMGN) stake by 26% in Q4 2025, selling an estimated $90.1K and leaving 800 shares worth $262K. The position accounts for 1.13% of the portfolio, ranked #23.
Northwest Capital Management first reported a position in AMGN in Q4 2017 and has held it in 33 quarters since. The position peaked at $967K in Q3 2024. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Northwest Capital Management held 800 shares of Amgen worth $262K as of Q4 2025.
- Northwest Capital Management sold 284 Amgen shares in Q4 2025, an estimated $90.1K.
- Amgen made up 1.13% of Northwest Capital Management's portfolio in Q4 2025, its #23 holding.
- Northwest Capital Management first reported a position in Amgen in Q4 2017 and has held it in 33 quarters since.
- Northwest Capital Management's Amgen position peaked at $967K in Q3 2024.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Northwest Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.